Aclara Biosciences is a startup based in the United States, most recent round Pre-ipo.
Aclara Biosciences is a startup based in the United States. Its most recent tracked round is Pre-ipo.
Aclara Biosciences developed innovative microfluidics technology that automated genetic sequencing and laboratory functions, and went public in 2000.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.